Literature DB >> 13361273

The effects of metabolic alterations on experimental Rhizopus oryzae (mucormycosis) infection.

H BAUER, J F FLANAGAN, W H SHELDON.   

Abstract

Entities:  

Keywords:  DIABETES MELLITUS/experimental; FUNGUS DISEASES/experimental

Mesh：

Year:  1956        PMID： 13361273      PMCID： PMC2603718     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN： 0044-0086


× No keyword cloud information.
  7 in total

1.  Cerebral mucormycosis: pathogenesis of the disease; description of the fungus, Rhizopus oryzae, isolated from a fatal case.

Authors:  H BAUER; L AJELLO; E ADAMS; D U HERNANDEZ
Journal:  Am J Med       Date:  1955-05       Impact factor: 4.965

2.  Mucormycosis; report of a case.

Authors:  J S HARRIS
Journal:  Pediatrics       Date:  1955-12       Impact factor: 7.124

3.  Pulmonary mucormycosis in rabbits with alloxan diabetes; increased invasiveness of fungus during acute toxic phase of diabetes.

Authors:  T D ELDER; R D BAKER
Journal:  AMA Arch Pathol       Date:  1956-02

4.  The influence of glucose, fructose, and insulin on the metabolism of leukocytes of healthy and diabetic subjects.

Authors:  S P MARTIN; G R McKINNEY; R GREEN; C BECKER
Journal:  J Clin Invest       Date:  1953-11       Impact factor: 14.808

5.  The relationship between ascorbic acid and phagocytic activity.

Authors:  W J NUNGESTER; A M AMES
Journal:  J Infect Dis       Date:  1948 Jul-Aug       Impact factor: 5.226

6.  Resistance to infection in the alloxan-diabetic rabbit.

Authors:  A H CRUICKSHANK
Journal:  J Pathol Bacteriol       Date:  1954-04

7.  Antipneumococcal powers of the blood in alloxan diabetes in the rabbit.

Authors:  A H CRUICKSHANK; T P B PAYNE
Journal:  Bull Johns Hopkins Hosp       Date:  1949-04
  7 in total
  10 in total

1.  Pulmonary mucormycosis in a harp seal caused by Mucor pusillus.

Authors:  W KAPLAN; L J GOSS; L AJELLO; M S IVENS
Journal:  Mycopathol Mycol Appl       Date:  1960-02-25

2.  An amphotericin B-resistant case of rhinocerebral mucor mycosis.

Authors:  J Barnert; W Behr; H Reich
Journal:  Infection       Date:  1985 May-Jun       Impact factor: 3.553

Review 3.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

4.  Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus.

Authors:  A R Waldorf; N Ruderman; R D Diamond
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

5.  Monocyte-mediated damage to Rhizopus oryzae hyphae in vitro.

Authors:  R D Diamond; C C Haudenschild; N F Erickson
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

6.  Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis.

Authors:  R Y Chinn; R D Diamond
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

7.  Neutrophil chemotactic responses induced by fresh and swollen Rhizopus oryzae spores and Aspergillus fumigatus conidia.

Authors:  A R Waldorf; R D Diamond
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

8.  Experimental cerebral zygomycosis in alloxan-diabetic rabbits I. Relationship of temperature tolerance of selected zygomycetes to pathogenicity.

Authors:  D J Reinhardt; W Kaplan; L Ajello
Journal:  Infect Immun       Date:  1970-10       Impact factor: 3.441

9.  Rhinocerebral mucormycosis in a diabetic ketoacidotic patient.

Authors:  H Reich; W Behr; J Barnert
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

10.  Factors influencing experimental candidiasis in mice. I. Alloxan diabetes.

Authors:  V T ANDRIOLE; H F HASENCLEVER
Journal:  Yale J Biol Med       Date:  1962-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.